SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Genaissance Pharmaceuticals (GNSC)
An SI Board Since September 2000
Posts SubjectMarks Bans Symbol
183 6 0 GNSC
Emcee:  Jim Oravetz Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
108LOL. gotta love it. chump change. (eom)mopgcw-8/29/2002
107280,000 might possibly have made an impression; 2.8m would have shown real confinigel bates-8/29/2002
106Genaissance Pharmaceuticals Reports Second Quarter and Half-Year Results, Announmopgcw-8/5/2002
105I think you're looking at this the wrong way round. Say, for the sake of arnigel bates-7/26/2002
104I think you're looking at this the wrong way round. Say, for the sake of arnigel bates-7/26/2002
103interesting thought, but wouldn't gnsc have had to disclose solid evidence omopgcw-7/25/2002
102Further idle though... at what point in the future (& it what circumstances)nigel bates-7/25/2002
101Just an idle thought... If one were planning a clinical trial for a new compoundnigel bates-7/23/2002
100NEW HAVEN, Conn., July 2/PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inigel bates-7/3/2002
99NEW HAVEN, Conn., June 4 /PRNewswire-FirstCall/ -- Yale University School of Mednigel bates-6/4/2002
98Genome anthologies for harvesting gene variants United States Patent 5,972,614Jim Oravetz-5/31/2002
97Message 17480759nigel bates-5/17/2002
96NEW YORK (Reuters Health) - Cholesterol-lowering drugs called statins may increanigel bates-5/14/2002
95They are a gamble, but potentially an enormously profitable one. That they are tnigel bates-5/14/2002
94nigel GNSC slipping today. Down as low as 1.64. What is your current take on GFindit-5/7/2002
93Another seller: SOURCE: Form 144 ISSUER: GENAISSANCE PHARMACEUTICALS INC SYMBOmopgcw-4/29/2002
92NEW HAVEN, Conn., April 26 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticalsnigel bates-4/26/2002
91Genaissance Pharmaceuticals Discovers Genetic Markers Associated With Response tnigel bates-4/26/2002
90.......have helped to execute our existing partnerships, clinical programs, and scaram(o)uche-4/25/2002
89Genaissance Pharmaceuticals Announces Management Promotions NEW HAVEN, Conn., Amopgcw-4/24/2002
88Genaissance Pharmaceuticals, Inc. To Present At RedChip Partners Investor Confermopgcw-4/23/2002
87<b>this year</b>...... scaram(o)uche-4/23/2002
86Genaissance Pharmaceuticals, Inc. Invites You to Participate in Its First Quartenigel bates-4/19/2002
85Wednesday April 17, 12:18 pm Eastern Time Press Release SOURCE: Genaissance Pharscaram(o)uche-4/17/2002
84Atherosclerosis 2002 Apr;161(2):425-31 Differential effect of two common polymmichael_f_murphy-4/10/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News